Free Trial

Alps Advisors Inc. Purchases 28,511 Shares of Genpact Limited (NYSE:G)

Genpact logo with Computer and Technology background

Alps Advisors Inc. increased its holdings in Genpact Limited (NYSE:G - Free Report) by 7.1% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 431,767 shares of the business services provider's stock after buying an additional 28,511 shares during the quarter. Alps Advisors Inc. owned about 0.25% of Genpact worth $21,752,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the business. Smartleaf Asset Management LLC increased its position in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after acquiring an additional 783 shares during the last quarter. Assetmark Inc. increased its position in shares of Genpact by 10.0% during the 4th quarter. Assetmark Inc. now owns 5,927 shares of the business services provider's stock valued at $255,000 after purchasing an additional 540 shares during the last quarter. Proficio Capital Partners LLC bought a new position in shares of Genpact in the 4th quarter worth approximately $983,000. Raymond James Financial Inc. bought a new position in shares of Genpact in the 4th quarter worth approximately $5,552,000. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Genpact by 4.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 14,468 shares of the business services provider's stock worth $621,000 after buying an additional 550 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Analysts Set New Price Targets

G has been the topic of several recent research reports. Robert W. Baird decreased their price objective on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Mizuho upped their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a research report on Tuesday, July 1st. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Finally, Needham & Company LLC restated a "buy" rating and set a $50.00 price objective on shares of Genpact in a research report on Monday, June 30th. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $50.14.

Read Our Latest Stock Analysis on Genpact

Insider Activity

In other Genpact news, Director Nicholas C. Gangestad bought 2,000 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was acquired at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director directly owned 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.80% of the company's stock.

Genpact Price Performance

G stock traded down $1.00 during mid-day trading on Friday, hitting $44.30. The company had a trading volume of 1,127,913 shares, compared to its average volume of 1,420,223. The company has a 50-day moving average price of $43.93 and a 200 day moving average price of $47.09. Genpact Limited has a 12-month low of $32.18 and a 12-month high of $56.76. The company has a market capitalization of $7.75 billion, a price-to-earnings ratio of 15.12, a P/E/G ratio of 1.93 and a beta of 0.94. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.48.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The firm's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.73 EPS. On average, research analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend is Thursday, September 11th. Genpact's dividend payout ratio is currently 23.21%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

7 Nuclear Stocks One Announcement Away from Exploding
Goldman Sachs Warns of 20% Market Drop—Are They Right?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines